The drugs may also cause severe allergic reactions including shortness of breath, red rash, hives, abdominal pain, difficulty swallowing, and chest tightness
The fat metabolism theory suggests GIPs effects on adipose tissue are crucial
The Medicare GLP1 Bridge program Starting July 1, 2026, the Medicare GLP1 Bridge provides coverage for GLP1 weight-loss medications for the first time under a temporary demonstration program
GLP-1 Beyond Diabetes Originally developed as treatments for diabetes to help with insulin resistance and blood sugar regulation , GLP-1 medications are now making headlines for their impact on weight loss
Navigating symptoms and choosing the foods that will best support you can be challenging, but a Registered Dietitian Nutritionist can help